🕵️ Innate Pharma SA ($IPHA)
SEC insider & ownership activity, last 12 months · CIK 1598599 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Sanofi | 9.1% | 13G | Apr 29, 2025 | filing ↗ | |
| Astrazeneca PLC | 8.3% | 13D | Dec 22, 2025 | filing ↗ | |
| Medimmune Limited | 8.3% | 13D | Dec 22, 2025 | filing ↗ | |
| Caisse DES Depots ET Consignations | 7.9% | 13D | Apr 25, 2025 | filing ↗ | |
| Epic Bpifrance | 6.9% | 13D | Apr 25, 2025 | filing ↗ | |
| Bpifrance Participations S.a. | 6.9% | 13D | Apr 25, 2025 | filing ↗ | |
| Bpifrance S.a. | 6.9% | 13D | Apr 25, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.